A few years ago I wrote a piece on those weird pharmaceutical names and their overwhelming advertising on TV – those “ask ...
Sun Pharma’s $11.75 billion acquisition of US-based Organon marks a major strategic shift towards biosimilars and specialty ...
Bayer received an FDA Untitled Letter this week for its prostate cancer drug Nubeqa, shortly after it launched a lawsuit ...
The pair will integrate real-time diagnostic data into marketing workflows, with the aim of helping pharmaceutical companies ...
Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and ...
Industry Leaders lists, an expansion of the TIME100 Most Influential Companies issue that dives deeper into 20 sectors to ...
The site is the final of seven planned facilities that Novartis committed to building as part of a $23 billion investment in U.S. manufacturing, which it announced last year. The ...
India and New Zealand signed a landmark FTA granting zero-duty access on all New Zealand tariff lines for Indian exports, ...
Voucher application details focus on AUD as a major driver of the U.S. substance use crisis and the genetic targeting of AD04 ...
New relationships between media organizations and Kalshi and Polymarket could raise serious questions about institutional ...
When the unexpected happens, how you react to, and deal with operational blind spots is critical. Here’s how to keep you ...
For as long as anyone in medical cannabis marketing can remember, the industry’s unofficial motto has been some variation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results